Submitted by Anonymous (not verified) on 16 July 2024 - 15:07
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorised